Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-05-12 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-05-15 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-05-15 | 2022-12-31 | 2022-08-08 | 2022-05-16 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||
net income | -15,946,000 | 1,573,000 | 27,425,000 | 27,425,000 | 44,398,000 | -33,419,000 | 14,315,000 | 7,078,000 | 7,078,000 | |||||||
adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||
depreciation and amortization | -3,125,000 | 3,375,000 | 3,250,000 | 3,250,000 | 8,653,000 | -2,248,000 | 2,920,000 | 2,533,000 | 2,533,000 | 6,692,000 | 167,000 | 1,972,000 | 5,707,000 | 1,127,000 | 182,000 | |
share-based compensation | -37,741,000 | 56,645,000 | 30,958,000 | 30,958,000 | 93,835,000 | -27,792,000 | 36,623,000 | 26,543,000 | 26,543,000 | 73,588,000 | -2,186,000 | 22,459,000 | 78,866,000 | 23,666,000 | 2,204,000 | |
share-based compensation granted to foundation | ||||||||||||||||
amortization of discount and accretion of interest on marketable securities | -1,888,000 | 580,000 | -675,000 | -675,000 | 420,000 | |||||||||||
changes in operating assets and liabilities: | ||||||||||||||||
accounts receivable | 13,877,000 | -9,760,000 | -632,000 | -632,000 | -6,865,000 | 663,000 | -1,292,000 | -399,000 | -399,000 | -6,015,000 | -2,520,000 | -5,760,000 | 239,000 | -1,385,000 | -3,127,000 | |
prepaid expenses and other assets | 16,960,000 | -16,987,000 | -9,770,000 | -9,770,000 | -6,773,000 | 38,252,000 | -17,306,000 | 2,107,000 | 2,107,000 | 7,502,000 | -1,811,000 | -162,000 | 852,000 | 4,700,000 | -8,545,000 | |
accounts payable | -2,736,000 | 10,068,000 | -3,844,000 | -3,844,000 | 22,461,000 | -33,723,000 | 9,625,000 | 12,043,000 | 12,043,000 | 12,243,000 | 5,374,000 | 3,816,000 | -11,946,000 | -6,176,000 | 882,000 | |
accrued expenses and other liabilities | 6,122,000 | 2,941,000 | 21,157,000 | 21,157,000 | 7,456,000 | 17,293,000 | -3,636,000 | 6,346,000 | 6,346,000 | 7,075,000 | 11,765,000 | 4,104,000 | -5,761,000 | 5,342,000 | 11,492,000 | |
deferred revenue | -59,186,000 | 18,402,000 | 44,101,000 | 44,101,000 | 60,299,000 | -37,431,000 | 14,545,000 | 35,704,000 | 35,704,000 | 57,105,000 | -6,322,000 | 30,966,000 | 52,988,000 | 26,492,000 | 1,031,000 | |
net cash from operating activities | -83,663,000 | 66,837,000 | 111,970,000 | 111,970,000 | 224,460,000 | -61,144,000 | 55,794,000 | 91,955,000 | 91,955,000 | 148,825,000 | 18,990,000 | 42,728,000 | 7,108,000 | -12,912,000 | 4,148,000 | |
capital expenditures | 6,349,000 | -6,808,000 | -4,466,000 | -4,466,000 | -11,042,000 | 2,841,000 | -4,973,000 | -2,061,000 | -2,061,000 | -8,770,000 | -32,000 | -4,046,000 | -12,930,000 | -3,280,000 | -1,537,000 | |
free cash flows | -77,314,000 | 60,029,000 | 107,504,000 | 107,504,000 | 213,418,000 | -58,303,000 | 50,821,000 | 89,894,000 | 89,894,000 | 140,055,000 | 18,958,000 | 38,682,000 | -5,822,000 | -16,192,000 | 2,611,000 | |
cash flows from investing activities: | ||||||||||||||||
purchase of property and equipment | 5,587,000 | -5,884,000 | -3,687,000 | -3,687,000 | -9,411,000 | 2,164,000 | -4,504,000 | -1,460,000 | -1,460,000 | -7,122,000 | 344,000 | -3,561,000 | -10,664,000 | -2,354,000 | -1,665,000 | |
purchase of marketable securities | -139,481,000 | 0 | -10,049,000 | -10,049,000 | 0 | |||||||||||
capitalized software development costs | 762,000 | -924,000 | -779,000 | -779,000 | -1,631,000 | 677,000 | -469,000 | -601,000 | -601,000 | -1,648,000 | -376,000 | -485,000 | -2,266,000 | -926,000 | 128,000 | |
net cash from investing activities | -133,132,000 | -6,808,000 | -14,515,000 | -14,515,000 | -17,042,000 | -46,729,000 | -4,973,000 | -2,061,000 | -2,061,000 | -8,770,000 | -32,000 | -4,046,000 | -12,930,000 | -3,280,000 | 8,568,000 | |
cash flows from financing activities: | ||||||||||||||||
proceeds from exercise of share options and employee share purchase plan | -18,456,000 | 12,365,000 | 14,136,000 | 14,136,000 | 27,992,000 | -3,975,000 | 10,616,000 | 8,708,000 | 8,708,000 | 16,892,000 | -916,000 | 5,086,000 | 8,609,000 | |||
receipt (repayment) of tax advance relating to exercises of share options and rsus | 13,151,000 | -6,961,000 | 5,903,000 | |||||||||||||
net cash from financing activities | -25,387,000 | 2,881,000 | 18,548,000 | 18,548,000 | 41,143,000 | -19,328,000 | 14,877,000 | 18,522,000 | 18,522,000 | 25,286,000 | -7,877,000 | 10,989,000 | -13,044,000 | 25,383,000 | -21,044,000 | -745,471,000 |
increase in cash, and cash equivalents | -242,182,000 | 62,910,000 | 116,003,000 | 116,003,000 | -127,201,000 | 65,698,000 | 108,416,000 | 108,416,000 | 11,081,000 | |||||||
cash and cash equivalents - beginning of period | 178,913,000 | 0 | 1,411,602,000 | 1,411,602,000 | 174,114,000 | 0 | 1,116,128,000 | 1,116,128,000 | 53,812,000 | |||||||
cash and cash equivalents - end of period | -63,269,000 | 62,910,000 | 1,527,605,000 | 1,527,605,000 | 46,913,000 | 65,698,000 | 1,224,544,000 | 1,224,544,000 | 64,893,000 | |||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||
receipt (repayment)of tax advance relating to exercises of share options and rsus | ||||||||||||||||
non-cash investing and financing activities: | ||||||||||||||||
non-cash purchases of property and equipment | ||||||||||||||||
capitalized share-based compensation costs | ||||||||||||||||
right-of-use asset recognized with corresponding lease liability | ||||||||||||||||
receipt of tax advance relating to exercises of share options and rsus | 4,412,000 | 4,412,000 | 4,261,000 | 9,814,000 | 9,814,000 | |||||||||||
loss from sale of property and equipment | ||||||||||||||||
charitable share contribution to foundation | ||||||||||||||||
investment in affiliated company | ||||||||||||||||
adjustments to reconcile net income to cash from operating activities: | ||||||||||||||||
investments in affiliated company | ||||||||||||||||
capital lease payments | -66,000 | -21,000 | -11,000 | -2,000 | ||||||||||||
increase in cash, cash equivalents | ||||||||||||||||
cash, cash equivalents – beginning of year | ||||||||||||||||
cash, cash equivalents – end of year | ||||||||||||||||
supplemental disclosure: | ||||||||||||||||
cash paid for taxes | ||||||||||||||||
cash paid for interest | ||||||||||||||||
● | ||||||||||||||||
monday.com and subsidiaries | ||||||||||||||||
net loss | -14,667,000 | -113,837,000 | -66,678,000 | |||||||||||||
adjustments to reconcile net loss to cash from operating activities: | ||||||||||||||||
capital loss from sale of property and equipment | ||||||||||||||||
change in accrued interest on revolving credit facility | -33,000 | |||||||||||||||
proceeds from sale of property and equipment | ||||||||||||||||
changes in short-term deposits | 10,102,000 | |||||||||||||||
cash flows from financing activities | ||||||||||||||||
proceeds from initial public offering and concurrent private placement, net of underwriting discounts and other issuance costs | -736,391,000 | |||||||||||||||
receipt (payment) of tax advance relating to exercises of share options and restricted share units | ||||||||||||||||
repayment of revolving credit facility | ||||||||||||||||
cash, cash equivalents - beginning of year | ||||||||||||||||
cash, cash equivalents - end of year | ||||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | ||||||||||||||||
increase in cash, cash equivalents and restricted cash | 49,671,000 | -18,866,000 | -732,755,000 | |||||||||||||
cash, cash equivalents and restricted cash – beginning of period | 885,894,000 | |||||||||||||||
cash, cash equivalents and restricted cash – end of period | 935,565,000 | |||||||||||||||
reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet: | ||||||||||||||||
cash and cash equivalents | 935,565,000 | 33,326,000 | -14,956,000 | 849,576,000 | 10,892,000 | |||||||||||
total cash, cash equivalents, and restricted cash | 935,565,000 | 33,326,000 | -14,956,000 | 849,576,000 | 8,292,000 | |||||||||||
cash, cash equivalents and restricted cash - beginning of period | -37,236,000 | 886,812,000 | 741,047,000 | |||||||||||||
cash, cash equivalents and restricted cash - end of period | -14,956,000 | 849,576,000 | 8,292,000 | |||||||||||||
receipt (payment) of tax advance relating to exercises of share options and rsus | ||||||||||||||||
receipt (repayment) of revolving credit facility, net of payments | ||||||||||||||||
cash, cash equivalents and restricted cash – beginning of year | ||||||||||||||||
cash, cash equivalents and restricted cash – end of year | ||||||||||||||||
unpaid deferred offering costs | ||||||||||||||||
share-based compensation included in capitalized software development costs | ||||||||||||||||
restricted cash – included in other long-term assets | ||||||||||||||||
receipt of tax advance relating to exercises of share options | 11,477,000 | |||||||||||||||
restricted cash – included in prepaid expense and other current assets | ||||||||||||||||
payments in connection with deferred offering costs | ||||||||||||||||
proceeds from exercise of share options | 1,351,000 | 445,000 | ||||||||||||||
receipt (repayment) of tax advance relating to exercises of share options | -22,384,000 | |||||||||||||||
decrease in cash, cash equivalents and restricted cash | -37,236,000 | |||||||||||||||
receipt (repayment) of revolving credit facility | ||||||||||||||||
proceeds from issuance of preferred shares | ||||||||||||||||
additions to capital leases | ||||||||||||||||
capital income from sale of property and equipment | ||||||||||||||||
receipt of revolving credit facility, net of payments | ||||||||||||||||
• |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
